Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomoki Naoe

Showing results (231-240 of 288) with videos related to

Pageof 29
Sort By:
Cancer Science|April 24, 2010
Central nervous system involvement in intravascular large B-cell lymphoma: a retrospective analysis of 109 patientsKazuyuki Shimada, Takuhei Murase, Kosei Matsue, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 29, 2008
Retrospective analysis of intravascular large B-cell lymphoma treated with rituximab-containing chemotherapy as reported by the IVL study group in JapanKazuyuki Shimada, Kosei Matsue, Kazuhito Yamamoto, et al.
International Journal of Hematology|November 6, 2024
A phase 1/2 study of gilteritinib in combination with chemotherapy in newly diagnosed patients with AML in AsiaMasashi Sawa, Toshihiro Miyamoto, Hee-Je Kim, et al.
European Journal of Haematology|December 19, 2015
Unrelated bone marrow transplantation or immediate umbilical cord blood transplantation for patients with acute myeloid leukemia in first complete remissionMasamitsu Yanada, Junya Kanda, Shigeki Ohtake, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 4, 2018
Infectious complications in adults undergoing intensive chemotherapy for acute myeloid leukemia in 2001-2005 using the Japan Adult Leukemia Study Group AML201 protocolsHideaki Kato, Hiroyuki Fujita, Nobu Akiyama, et al.
Therapeutic Advances in Hematology|March 16, 2026
A phase I/II study of gilteritinib in combination with chemotherapy in newly diagnosed patients with AML in Asia: final analysisMasashi Sawa, Toshihiro Miyamoto, Hee-Je Kim, et al.
International Journal of Hematology|September 11, 2010
Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia: the JALSG-ALL97 studyItsuro Jinnai, Tohru Sakura, Motohiro Tsuzuki, et al.
Stem Cell Reports|May 29, 2018
Generation of TCR-Expressing Innate Lymphoid-like Helper Cells that Induce Cytotoxic T Cell-Mediated Anti-leukemic Cell ResponseNorihiro Ueda, Yasushi Uemura, Rong Zhang, et al.
British Journal of Haematology|November 7, 2008
Prospective monitoring of BCR-ABL1 transcript levels in patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia undergoing imatinib-combined chemotherapyMasamitsu Yanada, Isamu Sugiura, Jin Takeuchi, et al.
International Journal of Hematology|March 11, 2020
Treatment outcomes of chronic-phase chronic myeloid leukemia with resistance and/or intolerance to a 1st-line tyrosine kinase inhibitor in Japan: the results of the New TARGET study 2nd-lineMasatoshi Sakurai, Shinichiro Okamoto, Itaru Matsumura, et al.
Pageof 29

Showing results (231-240 of 288) with videos related to

Sort By:
Pageof 29
Cancer Science|April 24, 2010
Central nervous system involvement in intravascular large B-cell lymphoma: a retrospective analysis of 109 patientsKazuyuki Shimada, Takuhei Murase, Kosei Matsue, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 29, 2008
Retrospective analysis of intravascular large B-cell lymphoma treated with rituximab-containing chemotherapy as reported by the IVL study group in JapanKazuyuki Shimada, Kosei Matsue, Kazuhito Yamamoto, et al.
International Journal of Hematology|November 6, 2024
A phase 1/2 study of gilteritinib in combination with chemotherapy in newly diagnosed patients with AML in AsiaMasashi Sawa, Toshihiro Miyamoto, Hee-Je Kim, et al.
European Journal of Haematology|December 19, 2015
Unrelated bone marrow transplantation or immediate umbilical cord blood transplantation for patients with acute myeloid leukemia in first complete remissionMasamitsu Yanada, Junya Kanda, Shigeki Ohtake, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 4, 2018
Infectious complications in adults undergoing intensive chemotherapy for acute myeloid leukemia in 2001-2005 using the Japan Adult Leukemia Study Group AML201 protocolsHideaki Kato, Hiroyuki Fujita, Nobu Akiyama, et al.
Therapeutic Advances in Hematology|March 16, 2026
A phase I/II study of gilteritinib in combination with chemotherapy in newly diagnosed patients with AML in Asia: final analysisMasashi Sawa, Toshihiro Miyamoto, Hee-Je Kim, et al.
International Journal of Hematology|September 11, 2010
Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia: the JALSG-ALL97 studyItsuro Jinnai, Tohru Sakura, Motohiro Tsuzuki, et al.
Stem Cell Reports|May 29, 2018
Generation of TCR-Expressing Innate Lymphoid-like Helper Cells that Induce Cytotoxic T Cell-Mediated Anti-leukemic Cell ResponseNorihiro Ueda, Yasushi Uemura, Rong Zhang, et al.
British Journal of Haematology|November 7, 2008
Prospective monitoring of BCR-ABL1 transcript levels in patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia undergoing imatinib-combined chemotherapyMasamitsu Yanada, Isamu Sugiura, Jin Takeuchi, et al.
International Journal of Hematology|March 11, 2020
Treatment outcomes of chronic-phase chronic myeloid leukemia with resistance and/or intolerance to a 1st-line tyrosine kinase inhibitor in Japan: the results of the New TARGET study 2nd-lineMasatoshi Sakurai, Shinichiro Okamoto, Itaru Matsumura, et al.
Pageof 29